rosiglitazone has been researched along with Invasiveness, Neoplasm in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Q; Guan, F; Jiang, M; Lin, J; Liu, L; Zhuang, X | 1 |
| Bae, YK; Cho, SJ; Choi, IJ; Kim, YW; Kook, MC; Lee, JH; Park, J; Ryu, KW; Shin, JY | 1 |
| Cao, LQ; Jiang, XF; Liang, HH; Shao, ZL; Xue, P; Yang, XW; Zhang, DW | 1 |
| Cao, LQ; Li, Y; Lin, DQ; Zhang, DW | 1 |
| Jan, HJ; Lai, JH; Lee, CC; Lee, HM; Lin, YM; Wei, HW | 1 |
| Hou, J; Lin, C; Ma, GD; Zhang, CQ; Zhang, LY | 1 |
| Belinsky, SA; Damiani, LA; Do, KC; Grimes, MJ; Klinge, DM; Lyon, CM; March, TH; Stidley, CA; Thomas, CL | 1 |
| Knight, BB; Nagalingam, A; Oberlick, E; Saxena, NK; Sharma, D; Taliaferro-Smith, L | 1 |
| Elstner, E; Fenner, MH; Liu, H; Possinger, K; Zang, C | 1 |
| Evers, BM; Farrow, B; Hashimoto, K; Iwamura, T; O'Connor, KL | 1 |
| Casini, A; Ceni, E; Crabb, DW; Galli, A; Grappone, C; Mello, T; Milani, S; Salzano, R; Surrenti, C; Surrenti, E | 1 |
| Ceni, E; Ferruzzi, P; Fiorelli, G; Galli, A; Grappone, C; Mannelli, M; Milani, S; Serio, M; Tarocchi, M | 1 |
| Baek, HA; Choi, HN; Chung, MJ; Jang, KY; Kim, KR; Lee, HJ; Moon, WS; Park, HS | 1 |
| Borenstein, X; Jasnis, MA; Magenta, G; Rolando, R | 1 |
14 other study(ies) available for rosiglitazone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.
Topics: Angiopoietin-Like Protein 4; Cell Movement; Cell Proliferation; Cell Survival; Female; Human Umbilical Vein Endothelial Cells; Humans; Models, Biological; Neoplasm Invasiveness; Neovascularization, Physiologic; PPAR gamma; Pre-Eclampsia; Pregnancy; Promoter Regions, Genetic; Protective Agents; Protein Binding; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Trophoblasts | 2017 |
Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Galectins; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Transplantation; PPAR gamma; Prognosis; Promoter Regions, Genetic; Proportional Hazards Models; Protein Binding; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Up-Regulation; Zebrafish | 2015 |
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Caspase 9; Cell Movement; Cell Proliferation; Computational Biology; Down-Regulation; Electrophoresis, Gel, Two-Dimensional; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; PPAR gamma; Proteomics; RNA Interference; Rosiglitazone; Septins; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thiazolidinediones; Transfection | 2015 |
Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
Topics: Cell Line, Tumor; Cell Movement; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Pancreatic Neoplasms; PPAR gamma; PTEN Phosphohydrolase; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitazone reduces cell invasiveness by inducing MKP-1 in human U87MG glioma cells.
Topics: Cell Line, Tumor; Dual Specificity Phosphatase 1; Glioma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2009 |
[Role of histone deacetylase in inhibiting invasion of human gastric carcinoma cell line SGC-7901 by PPARgamma-mediated pathway].
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Matrix Metalloproteinase 2; Neoplasm Invasiveness; PPAR gamma; RNA, Messenger; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones | 2009 |
Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model.
Topics: Adenoma; Animals; Antioxidants; Cell Line, Tumor; Disease Progression; Female; Histone Deacetylases; Humans; Hypoglycemic Agents; Immunohistochemistry; Lung Neoplasms; Mice; Neoplasm Invasiveness; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |
Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.
Topics: Adiponectin; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Leptin; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2013 |
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.
Topics: Breast Neoplasms; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Nuclear Proteins; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinases; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 2003 |
Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
Topics: Chromans; Humans; Integrins; Matrix Metalloproteinase Inhibitors; Neoplasm Invasiveness; Pancreatic Neoplasms; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Tissue Plasminogen Activator; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Male; Matrix Metalloproteinases; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Pioglitazone; Plasminogen Activators; PPAR gamma; RNA, Messenger; RNA, Neoplasm; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2004 |
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Cell Division; Cell Line, Tumor; Female; Humans; Hypoglycemic Agents; Matrix Metalloproteinase 2; Middle Aged; Neoplasm Invasiveness; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2005 |
A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Topics: Anilides; Benzamides; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Chromans; Colony-Forming Units Assay; Humans; Hypoglycemic Agents; Immunoenzyme Techniques; Ligands; Liver Neoplasms; Neoplasm Invasiveness; PPAR gamma; Pyridines; Rosiglitazone; Thiazolidinediones; Troglitazone; Vimentin | 2007 |
Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
Topics: Administration, Oral; Anilides; Animals; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Nitric Oxide; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured | 2008 |